Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: July 9, 2021
Amidst the myriad of disruptions and corollary solutions budding from the ongoing global COVID-19 pandemic, management of acne with isotretinoin un...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: May 7, 2020
A 59-year-old woman with a history of basal cell carcinoma, uterine and ovarian cancer, and verrucae presented with an asymptomatic 3-mm lesion on ...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: May 10, 2019
Total-body skin examination is the bedrock on which most general dermatologists’ clinic days are built. Dr. Lorraine Rosamilia provides practical t...
Audio
- Author:
- Lorraine L. Rosamilia, MD
Publish date: July 27, 2018
In this episode of the “Peer to Peer” podcast series with Dr. Vincent DeLeo, Dr. Lorraine L. Rosamilia outlines some underlying factors that lead t...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: July 5, 2018
We are fortunate to have plentiful acne treatment options available that cater to each patient’s clinical examination, predispositions, and trigger...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: December 1, 2017
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: July 5, 2017
When tasked with outlining updated therapy regimens for rosacea, specific patient vignettes come to mind. A 53-year-old male golfer presents with y...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: July 1, 2016
Inundating our popular and academic media circles is information regarding the Zika virus. A recent article by Farahnik et al in the Journal of ...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: April 5, 2016
In a case study published online on March 2 in JAMA Dermatology, Geller et al examined the relationship between total nevi, atypical nevi, a...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: January 21, 2016
In a JAMA Dermatology article published online on December 2, Lee et al challenged the commonly held belief that laboratory studies should b...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: November 23, 2015
In September 2015, the US Food and Drug Administration approved adalimumab, the well-known injectable tumor necrosis factor (TNF)–α inhibitor indic...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: September 14, 2015
Melanoma is unpredictable, making patient visits and communications complicated. Following the initial diagnosis, individualized patient care is ke...
Video
- Author:
- Lorraine L. Rosamilia, MD
Publish date: September 14, 2015
Melanoma has become more diverse in terms of the patients affected and the treatment course. Dr. Lorraine L. Rosamilia discusses individualized mel...
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: July 7, 2015
At the recent American Society of Clinical Oncology Annual Meeting, Read More
Article
- Author:
- Lorraine L. Rosamilia, MD
Publish date: April 28, 2015
Clarke et al published a study online on March 2 in the Journal of Cutaneous Pathology regarding a novel diagnostic test for melanoma. Using...
